HAE

Haemonetics (HAE)

Haemonetics Corp

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:HAE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/18	06 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	05 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	05 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	05 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	05 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/18	01 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/17	23 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/17	23 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/17	01 : 57	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/17	01 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/17	01 : 12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/05/09	19 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HAE	Haemonetics Corp
2024/05/09	19 : 00	PR Newswire (US)	Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website	NYSE:HAE	Haemonetics Corp
2024/05/09	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/07	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:HAE	Haemonetics Corp
2024/05/07	03 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:HAE	Haemonetics Corp
2024/04/11	05 : 58	PR Newswire (US)	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024	NYSE:HAE	Haemonetics Corp
2024/04/04	19 : 30	PR Newswire (US)	Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge	NYSE:HAE	Haemonetics Corp
2024/04/01	21 : 00	PR Newswire (US)	Haemonetics Corporation Completes Acquisition of Attune Medical	NYSE:HAE	Haemonetics Corp
2024/03/05	20 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:HAE	Haemonetics Corp
2024/03/05	20 : 00	PR Newswire (US)	Haemonetics Announces Definitive Agreement to Acquire Attune Medical	NYSE:HAE	Haemonetics Corp
2024/02/22	07 : 57	PR Newswire (US)	Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference	NYSE:HAE	Haemonetics Corp
2024/02/22	07 : 55	PR Newswire (US)	Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day	NYSE:HAE	Haemonetics Corp
2024/02/14	05 : 28	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:HAE	Haemonetics Corp
2024/02/10	07 : 49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:HAE	Haemonetics Corp
2024/02/09	00 : 21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:HAE	Haemonetics Corp